Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine with or without dexmedetomidine for postoperative pain and function after rotator cuff repair
IRCT20160430027677N16Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bupivacaine and dexmedetomidine in postoperative pain, sponsored by Urmia University of Medical Sciences. Primary endpoints: pain and function. Started Jan 2019; status: completed.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20160430027677N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160430027677N16.